Laura Roth

714 total citations
10 papers, 332 citations indexed

About

Laura Roth is a scholar working on Genetics, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura Roth has authored 10 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Pathology and Forensic Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura Roth's work include Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Laura Roth is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Lymphoma Diagnosis and Treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Laura Roth collaborates with scholars based in United States, China and France. Laura Roth's co-authors include Evgeny Arons, Robert J. Kreitman, Sean Davis, Robert L. Walker, Ogan D. Abaan, Paul S. Meltzer, Joshua J. Waterfall, J. Keith Killian, Marbin Pineda and Maryalice Stetler‐Stevenson and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Laura Roth

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Roth United States 7 196 161 90 85 77 10 332
Hiroshi Arima Japan 13 57 0.3× 108 0.7× 89 1.0× 141 1.7× 116 1.5× 36 383
Yukari Yamamoto Japan 10 163 0.8× 199 1.2× 20 0.2× 78 0.9× 29 0.4× 21 497
D Catovsky United Kingdom 12 244 1.2× 185 1.1× 204 2.3× 58 0.7× 107 1.4× 26 379
M. Mulargia Italy 11 40 0.2× 107 0.7× 99 1.1× 16 0.2× 28 0.4× 22 308
Jan‐Willem Vaandrager Netherlands 11 200 1.0× 245 1.5× 109 1.2× 219 2.6× 136 1.8× 16 519
Venkata J. Thodima United States 11 52 0.3× 69 0.4× 161 1.8× 119 1.4× 113 1.5× 17 363
Martha Romero Colombia 9 58 0.3× 338 2.1× 35 0.4× 102 1.2× 114 1.5× 20 488
Masuko Tagawa Japan 12 114 0.6× 50 0.3× 231 2.6× 97 1.1× 70 0.9× 26 523
Athanasios Koulis United Kingdom 8 70 0.4× 137 0.9× 110 1.2× 79 0.9× 93 1.2× 12 321
Daisuke Imanishi Japan 14 64 0.3× 49 0.3× 195 2.2× 108 1.3× 77 1.0× 38 431

Countries citing papers authored by Laura Roth

Since Specialization
Citations

This map shows the geographic impact of Laura Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Roth more than expected).

Fields of papers citing papers by Laura Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Roth. The network helps show where Laura Roth may publish in the future.

Co-authorship network of co-authors of Laura Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Roth. A scholar is included among the top collaborators of Laura Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Roth. Laura Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Klitting, Raphaëlle, Laura Roth, F.A. Rey, & Xavier de Lamballerie. (2018). Molecular determinants of Yellow Fever Virus pathogenicity in Syrian Golden Hamsters: one mutation away from virulence. Emerging Microbes & Infections. 7(1). 1–18. 15 indexed citations
2.
McKoy, June M., et al.. (2014). Are Telehealth Technologies for Hypertension Care and Self-Management Effective or Simply Risky and Costly?. Population Health Management. 18(3). 192–202. 13 indexed citations
3.
Waterfall, Joshua J., Evgeny Arons, Robert L. Walker, et al.. (2013). High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias. Nature Genetics. 46(1). 8–10. 180 indexed citations
4.
Kreitman, Robert J., Wyndham H. Wilson, Katherine R. Calvo, et al.. (2013). Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia. Clinical Cancer Research. 19(24). 6873–6881. 50 indexed citations
5.
Kreitman, Robert J., Evgeny Arons, Laura Roth, et al.. (2012). Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox.. Blood. 120(21). 2896–2896. 1 indexed citations
6.
Kreitman, Robert J., Evgeny Arons, Laura Roth, et al.. (2012). Durability of complete remission by moxetumomab pasudotox (HA22 or CAT-8015) assessed by clone-specific real-time quantitative PCR (RQ-PCR).. Journal of Clinical Oncology. 30(15_suppl). 2503–2503. 1 indexed citations
7.
Arons, Evgeny, et al.. (2011). Evidence of canonical somatic hypermutation in hairy cell leukemia. Blood. 117(18). 4844–4851. 24 indexed citations
9.
Roth, Laura. (2002). Government and Society: Standardizing food analysis. Analytical Chemistry. 74(3). 67 A–67 A.
10.
Drasga, R. E., et al.. (1984). Lymphomatoid granulomatosis. Successful treatment with CHOP combination chemotherapy.. PubMed. 7(1). 75–80. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026